Scientists highlight new insights into triple-negative breast cancer November 30, 2022 -- Boston University researchers have demonstrated that control of a certain cellular pathway can prevent the development of triple-negative breast cancer, which they contend could help identify new therapeutic options.Read More
Increasing immune cell production may reverse cognitive decline: study November 30, 2022 -- Rutgers University researchers have discovered that the underproduction of immune cells called mucosal-associated invariant T cells contribute to Alzheimer’s disease and other cognitive disorders. Their study, published November 21 in the journal Nature Immunology, shows how increasing these cells could reverse the damage.Read More
Manufacturing partnerships support high quality cell therapies May 3, 2022 -- Chimeric Therapeutics, Ncardia, and Novartis are some of the companies that have decided to partner to make complex manufacturing processes more efficient for novel therapies, according to Cell and Gene Therapy Business Outlook, a sister publication of ScienceBoard.Read More
Biocytogen partners with Merck to evaluate novel antibodies May 2, 2022 -- Biocytogen Pharmaceuticals has entered into an evaluation and option agreement with Merck KGaA to evaluate Biocytogen’s antibodies. The agreement will give Merck KGaA the license to assess these antibodies against three specified targets.Read More